Status:

UNKNOWN

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Lead Sponsor:

Mansoura University

Conditions:

Endometrial Disorder

Eligibility:

FEMALE

45-55 years

Phase:

NA

Brief Summary

Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women an...

Eligibility Criteria

Inclusion

  • \*perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and polymenorrhea.

Exclusion

  • \*general or local causes of bleeding, drug intake or recent hormonal contraception

Key Trial Info

Start Date :

August 8 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2018

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03351673

Start Date

August 8 2017

End Date

August 1 2018

Last Update

November 27 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

mansoura University

Al Mansurah, Dakahlia Governorate, Egypt, 35516

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding | DecenTrialz